Sixteen chordomas and nine chondrosarcomas of the clivus were evaluated with CT and MR either before (22 cases) or after (three cases) treatment with proton beam irradiation. The ability of these imaging techniques to provide information necessary to direct patient treatment was studied. The tumor was detected and its gross margins were identified by both techniques in all instances. No reliable diagnostic features allowing differentiation between these two tumors were encountered. MR generally was superior in defining the exact position of the brainstem and optic chiasm relative to the tumor, and it frequently provided superior information about tumor extension into the nasopharynx and cavernous sinus. CT was always better than MR in demonstrating tumoral calcification and in defining the exact anatomy of bone destruction. MR was generally superior to CT in demonstrating the position of the cavernous internal carotid artery relative to the tumor and often provided superior visualization of the vertebral and basilar arteries. In cases in which bone-induced artifact obscured the interface between the neural axis and tumor in the CT image, or in which the tumor had suprasellar extension and was likely to compress the optic chiasm and tracts, MR was of great value in planning irradiation therapy. The high occurrence of clinically asymptomatic signal intensity alterations in the MR studies of previously treated patients appears to limit the differential diagnostic value of this information. Given its greater availability and lower cost, CT appears to be the technique of choice for routine follow-up of previously treated patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2214/ajr.151.3.567 | DOI Listing |
Diagn Cytopathol
January 2025
Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Solitary plasmacytomas are localized single tumors of monoclonal plasma cells that occur in two variants: solitary plasmacytoma of bone and extraosseous plasmacytoma. Solitary plasmacytoma of bone accounts for only 1%-2% of plasma cell lesions, and extraosseous plasmacytoma is also approximately 1%. These are both very uncommon at the skull base.
View Article and Find Full Text PDFStudy Design: Systematic review.
Objectives: The objective of this review paper was to summarize targeted molecular therapy options for spinal chordoma and chondrosarcoma, and to provide an update on the relevant clinical trials open for recruitment.
Methods: A systematic review of the current literature was performed, according to PRISMA guidelines, to summarize the latest developments in non-surgical molecular treatment options for low grade malignant primary spinal tumours.
Global Spine J
January 2025
Combined Neurosurgical and Orthopedic Spine Program, Department of Orthopedics Surgery, University of British Columbia, Vancouver, BC, Canada.
Study Design: Narrative review.
Objectives: This article aims to provide a narrative review of the current state of research for liquid biopsy in spinal tumors and to discuss the potential application of liquid biopsy in the clinical management of patients with spinal tumors.
Methods: A comprehensive review of the literature was performed using PubMed, Google Scholar, Medline, Embase and Cochrane databases, and the review was limited to articles of English language.
J Neurooncol
December 2024
Department of Neurosurgery, Maastricht University Medical Center, P. Debyelaan 25, 6202 AZ, Maastricht, The Netherlands.
Purpose: Chordomas are malignant tumors of the axial spine and skull base, and they are notorious for their poor treatment response. Differentiating these tumors from comparatively less malignant chondrosarcomas is crucial for treatment and prognostication. Both tumor types differ in their developmental origin.
View Article and Find Full Text PDFEur Arch Otorhinolaryngol
October 2024
Barmherzige Brüder Klinikum St. Elisabeth Straubing, Klinik für Hals-Nasen-Ohren-Heilkunde mit Kopf-Hals- und plastischer Gesichtschirurgie, Straubing, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!